Index S&P 500 P/E 35.39 EPS (ttm) 6.92 Insider Own 0.80% Shs Outstand 146.90M Perf Week -1.60%
Market Cap 35.99B Forward P/E 24.44 EPS next Y 10.02 Insider Trans -11.79% Shs Float 145.75M Perf Month 9.20%
Income 1.02B PEG 2.28 EPS next Q 2.05 Inst Own 60.08% Short Float 5.86% Perf Quarter 19.00%
Sales 4.69B P/S 7.68 EPS this Y 18.28% Inst Trans -0.38% Short Ratio 7.68 Perf Half Y 26.43%
Book/sh 33.11 P/B 7.40 EPS next Y 9.74% ROA 14.99% Short Interest 8.55M Perf Year 73.57%
Cash/sh 1.62 P/C 150.99 EPS next 5Y 15.50% ROE 22.70% 52W Range 132.24 - 255.18 Perf YTD 42.39%
Dividend Est. 2.21 (0.90%) P/FCF 27.65 EPS past 5Y 19.83% ROI 17.90% 52W High -4.01% Beta 0.69
Dividend TTM 1.97 (0.80%) Quick Ratio 1.69 Sales past 5Y 12.49% Gross Margin 55.68% 52W Low 85.22% ATR (14) 6.83
Dividend Ex-Date Aug 15, 2024 Current Ratio 2.59 EPS Y/Y TTM 13.57% Oper. Margin 29.54% RSI (14) 56.93 Volatility 2.58% 2.60%
Employees 9980 Debt/Eq 0.18 Sales Y/Y TTM 10.95% Profit Margin 21.79% Recom 2.09 Target Price 236.28
Option/Short Yes / Yes LT Debt/Eq 0.17 EPS Q/Q 27.26% Payout 27.75% Rel Volume 1.41 Prev Close 242.98
Sales Surprise 0.40% EPS Surprise -0.13% Sales Q/Q 9.01% Earnings Aug 01 AMC Avg Volume 1.11M Price 244.94
SMA20 0.65% SMA50 8.76% SMA200 23.18% Trades
Volume 1,567,009 Change 0.81%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-18-24 Downgrade Wolfe Research
Peer Perform → Underperform
$180
Sep-04-24 Downgrade Needham
Buy → Hold
Jun-25-24 Downgrade Oppenheimer
Outperform → Perform
Jun-24-24 Downgrade Citigroup
Buy → Neutral
Feb-06-24 Resumed KeyBanc Capital Markets
Overweight
$227
Oct-27-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$180 → $169
Oct-12-23 Downgrade RBC Capital Mkts
Outperform → Sector Perform
$273 → $202
Oct-09-23 Upgrade JP Morgan
Neutral → Overweight
$210 → $170
Sep-29-23 Downgrade Wolfe Research
Outperform → Peer Perform
Sep-06-23 Upgrade Needham
Hold → Buy
$180
Sep-05-23 Downgrade UBS
Buy → Neutral
$265 → $170
Aug-01-23 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$262 → $284
May-23-23 Initiated UBS
Buy
$290
Apr-14-23 Initiated Mizuho
Buy
$255
Jan-17-23 Upgrade JP Morgan
Neutral → Overweight
$245
Oct-28-22 Downgrade Citigroup
Buy → Neutral
Oct-20-22 Upgrade BofA Securities
Neutral → Buy
$245 → $260
Oct-12-22 Initiated Jefferies
Hold
Sep-08-22 Upgrade Citigroup
Neutral → Buy
Aug-15-22 Downgrade CLSA
Buy → Outperform
Show Previous Ratings
Sep-18-24 05:49PM
05:15PM
01:30PM
12:37PM
11:24AM
01:24AM
Loading…
Sep-11-24 01:24AM
Sep-10-24 04:05PM
08:00AM
Sep-09-24 07:31PM
Sep-06-24 05:00PM
Aug-30-24 09:45AM
Aug-28-24 04:05PM
Aug-27-24 05:36PM
Aug-15-24 04:05PM
Aug-14-24 09:45AM
03:00PM
Loading…
Aug-12-24 03:00PM
Aug-10-24 01:05AM
Aug-09-24 02:07PM
Aug-08-24 09:50AM
Aug-06-24 11:32PM
12:35PM
(The Wall Street Journal)
Aug-02-24 08:11AM
08:10AM
Aug-01-24 06:30PM
05:15PM
04:36PM
(Associated Press Finance)
04:05PM
Jul-30-24 12:10PM
Jul-29-24 05:11PM
03:31PM
09:16AM
Loading…
09:16AM
Jul-25-24 10:01AM
Jul-11-24 09:45AM
01:30AM
Jul-10-24 01:29AM
Jul-05-24 09:00AM
Jul-03-24 04:05PM
Jul-02-24 01:47PM
Jul-01-24 01:38AM
Jun-29-24 09:00AM
Jun-27-24 12:01PM
Jun-24-24 05:07PM
04:10PM
(Investor's Business Daily)
04:08PM
02:10PM
02:01PM
01:26PM
12:52PM
(Associated Press Finance)
12:29PM
10:38AM
10:36AM
08:40AM
(The Wall Street Journal)
07:52AM
07:49AM
Jun-21-24 05:05PM
Jun-19-24 09:45AM
Jun-11-24 07:02PM
Jun-10-24 09:05AM
Jun-06-24 09:50AM
May-31-24 12:45PM
09:45AM
May-27-24 11:28AM
May-23-24 09:05AM
06:00AM
May-21-24 09:30AM
May-20-24 10:47AM
May-16-24 04:35PM
12:00PM
08:05AM
May-15-24 12:45PM
09:45AM
May-08-24 10:31AM
May-07-24 04:05PM
May-03-24 09:43AM
Apr-30-24 01:31PM
09:50AM
Apr-29-24 12:45PM
09:45AM
Apr-27-24 01:06AM
Apr-26-24 04:08PM
(Investor's Business Daily) +18.89%
03:57PM
02:12PM
01:48PM
12:17PM
12:08PM
11:45AM
(The Wall Street Journal)
11:35AM
11:26AM
11:01AM
10:33AM
10:12AM
10:00AM
(Investor's Business Daily)
08:58AM
08:47AM
08:37AM
08:07AM
07:53AM
06:39AM
06:33AM
(Thomson Reuters StreetEvents)
06:16AM
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ghoshal Kaushik Chief Commercial Officer, SaaS Sep 12 '24 Option Exercise 101.64 5,000 508,200 26,788 Sep 13 02:54 PM Ghoshal Kaushik Chief Commercial Officer, SaaS Sep 12 '24 Sale 252.56 5,000 1,262,800 21,788 Sep 13 02:54 PM Ghoshal Kaushik Officer Sep 12 '24 Proposed Sale 252.56 5,000 1,262,800 Sep 12 09:55 AM Sandercock Brett Chief Financial Officer Sep 09 '24 Sale 246.42 1,000 246,420 96,812 Sep 10 09:18 PM Farrell Michael J. Chief Executive Officer Sep 09 '24 Option Exercise 84.98 14,683 1,247,761 478,852 Sep 10 09:11 PM Farrell Michael J. Chief Executive Officer Sep 09 '24 Sale 248.38 14,683 3,646,950 464,169 Sep 10 09:11 PM Farrell Michael J. Officer Sep 09 '24 Proposed Sale 248.38 14,683 3,646,950 Sep 09 04:37 PM Sandercock Brett Officer Sep 09 '24 Proposed Sale 246.42 1,000 246,420 Sep 09 11:08 AM FARRELL PETER C Director Sep 04 '24 Sale 239.90 2,000 479,800 87,204 Sep 06 03:01 PM FARRELL PETER C Director Sep 04 '24 Proposed Sale 244.90 2,000 489,800 Sep 04 10:58 AM Rider Michael J Global General Counsel Aug 20 '24 Sale 231.00 882 203,742 10,512 Aug 21 02:29 PM Rider Michael J Officer Aug 20 '24 Proposed Sale 230.74 883 203,742 Aug 20 11:14 AM Ghoshal Kaushik President, SaaS Business Aug 12 '24 Option Exercise 96.41 10,000 964,056 23,032 Aug 13 03:51 PM Ghoshal Kaushik President, SaaS Business Aug 12 '24 Sale 216.60 10,000 2,166,000 13,032 Aug 13 03:51 PM Sandercock Brett Chief Financial Officer Aug 08 '24 Sale 212.16 1,000 212,160 89,056 Aug 12 11:57 AM Ghoshal Kaushik Officer Aug 12 '24 Proposed Sale 216.60 10,000 2,166,000 Aug 12 11:25 AM Farrell Michael J. Chief Executive Officer Aug 07 '24 Option Exercise 84.98 14,683 1,247,761 455,482 Aug 09 11:53 AM Farrell Michael J. Chief Executive Officer Aug 07 '24 Sale 214.25 14,683 3,145,905 440,799 Aug 09 11:53 AM Sandercock Brett Officer Aug 08 '24 Proposed Sale 212.16 1,000 212,160 Aug 08 12:33 PM Farrell Michael J. Officer Aug 07 '24 Proposed Sale 214.25 14,683 3,145,904 Aug 07 04:47 PM Leong Justin President, Asia Latin America Aug 05 '24 Sale 217.07 48,000 10,419,552 18,741 Aug 06 05:51 PM Leong Justin Officer Aug 05 '24 Proposed Sale 217.07 48,000 10,419,550 Aug 05 12:52 PM Farrell Michael J. Chief Executive Officer Jul 08 '24 Option Exercise 84.98 14,683 1,247,761 455,482 Jul 10 12:04 PM Farrell Michael J. Chief Executive Officer Jul 08 '24 Sale 192.97 14,683 2,833,330 440,799 Jul 10 12:04 PM Sandercock Brett Chief Financial Officer Jul 08 '24 Sale 194.35 1,000 194,350 90,056 Jul 09 05:27 PM Sandercock Brett Chief Financial Officer Jun 10 '24 Sale 209.81 1,000 209,810 91,056 Jun 11 05:05 PM Farrell Michael J. Chief Executive Officer Jun 07 '24 Option Exercise 84.98 14,683 1,247,761 455,482 Jun 10 09:58 PM Farrell Michael J. Chief Executive Officer Jun 07 '24 Sale 211.66 14,683 3,107,739 440,799 Jun 10 09:58 PM De Witte Jan Director May 15 '24 Sale 218.29 360 78,584 7,519 May 17 11:27 AM Sandercock Brett Chief Financial Officer May 08 '24 Option Exercise 101.64 12,000 1,219,680 105,056 May 10 03:21 PM Sandercock Brett Chief Financial Officer May 08 '24 Sale 211.37 13,000 2,747,810 92,056 May 10 03:21 PM Farrell Michael J. Chief Executive Officer May 07 '24 Option Exercise 84.98 14,683 1,247,761 455,435 May 09 11:58 AM Farrell Michael J. Chief Executive Officer May 07 '24 Sale 216.50 14,683 3,178,815 440,752 May 09 11:58 AM Drexler Karen Director Apr 29 '24 Sale 214.92 425 91,341 8,446 Apr 30 02:17 PM Rider Michael J Global General Counsel Mar 04 '24 Sale 180.00 81 14,580 6,607 Mar 06 08:46 PM Rider Michael J Global General Counsel Mar 01 '24 Sale 173.25 200 34,650 6,688 Mar 04 07:11 PM FARRELL PETER C Director Feb 22 '24 Sale 182.66 10,935 1,997,434 157,404 Feb 23 06:40 PM Sandercock Brett Chief Financial Officer Nov 27 '23 Sale 152.62 3,000 457,860 92,962 Nov 29 07:45 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Option Exercise 57.76 5,678 327,961 446,664 Nov 16 09:20 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Sale 152.04 5,678 863,281 440,986 Nov 16 09:20 PM Rider Michael J Global General Counsel Nov 01 '23 Sale 143.42 25 3,585 7,358 Nov 02 09:29 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Option Exercise 57.76 5,675 327,788 455,035 Oct 17 06:50 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Sale 140.70 5,675 798,464 449,360 Oct 17 06:50 PM Rider Michael J Global General Counsel Oct 02 '23 Sale 145.92 25 3,648 7,383 Oct 04 10:57 AM
Index RUT P/E 58.96 EPS (ttm) 0.30 Insider Own 16.14% Shs Outstand 78.17M Perf Week -0.40%
Market Cap 1.35B Forward P/E 6.94 EPS next Y 2.51 Insider Trans 0.71% Shs Float 65.06M Perf Month -17.26%
Income 23.65M PEG 9.36 EPS next Q 0.39 Inst Own 90.62% Short Float 7.40% Perf Quarter -41.04%
Sales 1.57B P/S 0.86 EPS this Y -20.99% Inst Trans 1.30% Short Ratio 3.23 Perf Half Y -49.46%
Book/sh 19.77 P/B 0.88 EPS next Y 2.32% ROA 0.60% Short Interest 4.81M Perf Year -55.29%
Cash/sh 3.83 P/C 4.55 EPS next 5Y 6.30% ROE 1.47% 52W Range 16.96 - 45.42 Perf YTD -60.05%
Dividend Est. - P/FCF 22.92 EPS past 5Y 3.10% ROI 0.67% 52W High -61.69% Beta 1.10
Dividend TTM - Quick Ratio 2.10 Sales past 5Y 1.17% Gross Margin 56.60% 52W Low 2.59% ATR (14) 0.78
Dividend Ex-Date - Current Ratio 3.39 EPS Y/Y TTM -81.32% Oper. Margin 11.83% RSI (14) 24.92 Volatility 3.93% 3.86%
Employees 5329 Debt/Eq 1.31 Sales Y/Y TTM 1.37% Profit Margin 1.51% Recom 3.29 Target Price 27.70
Option/Short Yes / Yes LT Debt/Eq 1.28 EPS Q/Q -410.47% Payout 0.00% Rel Volume 1.64 Prev Close 17.47
Sales Surprise 1.24% EPS Surprise 1.04% Sales Q/Q 9.68% Earnings Jul 29 BMO Avg Volume 1.49M Price 17.40
SMA20 -7.96% SMA50 -24.82% SMA200 -46.29% Trades
Volume 2,452,283 Change -0.40%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-30-24 Downgrade Citigroup
Neutral → Sell
$30 → $23
Jul-30-24 Downgrade BTIG Research
Neutral → Sell
$22
May-07-24 Downgrade Wells Fargo
Overweight → Equal Weight
$45 → $25
May-07-24 Downgrade Oppenheimer
Outperform → Perform
Apr-03-24 Upgrade Citigroup
Sell → Neutral
$38
Dec-05-23 Upgrade Wells Fargo
Equal Weight → Overweight
$40 → $49
Nov-14-23 Initiated CL King
Buy
$50
Aug-24-23 Downgrade Morgan Stanley
Equal-Weight → Underweight
$44
Jul-12-23 Upgrade Jefferies
Hold → Buy
$58 → $53
Jun-08-23 Downgrade Argus
Buy → Hold
May-24-23 Downgrade JP Morgan
Neutral → Underweight
$56 → $43
May-23-23 Downgrade Citigroup
Neutral → Sell
$59 → $39
Oct-12-22 Initiated Jefferies
Hold
Jul-25-22 Initiated Morgan Stanley
Equal-Weight
$59
Apr-13-22 Downgrade Truist
Buy → Hold
$72 → $71
Dec-17-21 Upgrade JP Morgan
Underweight → Neutral
$75
Sep-15-21 Downgrade BTIG Research
Buy → Neutral
Oct-08-20 Downgrade JP Morgan
Neutral → Underweight
$55 → $50
May-27-20 Initiated Citigroup
Neutral
$54
Apr-03-20 Initiated SunTrust
Buy
$55
Show Previous Ratings
Sep-11-24 02:30AM
Sep-04-24 04:01PM
10:32AM
Aug-21-24 04:15PM
Jul-30-24 12:49PM
03:29AM
Loading…
03:29AM
(Thomson Reuters StreetEvents)
Jul-29-24 12:23PM
09:30AM
07:15AM
06:13AM
(Associated Press Finance)
06:00AM
Jul-22-24 10:01AM
Jul-19-24 08:34AM
Jul-17-24 08:00AM
Jul-16-24 09:14AM
08:00AM
Loading…
Jul-15-24 08:00AM
08:00AM
Jun-07-24 06:09PM
Jun-05-24 11:30AM
May-30-24 05:39PM
May-28-24 01:34PM
04:22AM
May-17-24 07:54AM
May-13-24 04:30PM
12:07PM
May-08-24 12:15AM
May-07-24 11:33AM
11:10AM
08:02AM
07:27AM
07:19AM
Loading…
07:19AM
03:02AM
01:45AM
(Thomson Reuters StreetEvents)
May-06-24 01:23PM
12:35PM
12:35PM
(Associated Press Finance)
10:53AM
09:30AM
06:29AM
06:10AM
(Associated Press Finance)
06:00AM
Apr-30-24 04:20PM
Apr-18-24 05:24PM
Apr-17-24 10:01AM
Apr-09-24 08:41AM
Apr-01-24 04:15PM
Mar-29-24 11:30AM
Mar-13-24 08:17AM
Mar-12-24 12:04PM
Mar-11-24 08:30AM
Feb-29-24 11:46AM
10:43AM
05:52AM
Feb-28-24 10:46PM
(Thomson Reuters StreetEvents) -12.65%
09:30AM
07:15AM
06:32AM
06:28AM
06:25AM
(Associated Press Finance)
06:00AM
06:00AM
Feb-27-24 05:03AM
Feb-26-24 09:15AM
Feb-21-24 10:00AM
Feb-07-24 09:15AM
Jan-20-24 03:19PM
Jan-10-24 07:13AM
Jan-05-24 04:30PM
Dec-14-23 11:14AM
Dec-13-23 06:15AM
06:04AM
Dec-12-23 12:00PM
Nov-24-23 11:31AM
Nov-08-23 08:00AM
Oct-26-23 10:52AM
08:20AM
Oct-25-23 09:30AM
08:06AM
07:15AM
06:13AM
(Associated Press Finance)
06:00AM
Oct-13-23 11:40AM
Oct-11-23 06:53PM
Oct-10-23 05:38PM
Oct-05-23 08:25AM
Oct-04-23 08:00AM
Sep-28-23 11:49AM
Sep-27-23 05:56PM
Sep-07-23 07:37PM
Sep-01-23 05:04PM
Aug-31-23 08:37AM
Aug-25-23 11:31AM
10:26AM
Aug-13-23 05:49PM
Aug-10-23 08:51AM
Aug-07-23 02:28PM
Jul-28-23 11:12AM
Jul-26-23 08:00PM
07:45PM
06:39PM
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mosebrook Jeffrey SVP, Fin & Princ Acct Officer Aug 19 '24 Sale 21.58 1,191 25,701 36,088 Aug 20 04:22 PM ESSIG STUART Exec. Chairman of the Board May 23 '24 Buy 28.49 52,641 1,499,979 487,922 May 24 04:08 PM HILL BARBARA B Director May 21 '24 Buy 27.40 36,350 995,816 36,350 May 22 04:09 PM De Witte Jan President & CEO Mar 11 '24 Option Exercise 0.00 205 0 18,555 Mar 13 04:30 PM De Witte Jan President & CEO Mar 10 '24 Option Exercise 0.00 346 0 18,696 Mar 12 05:12 PM Singh Harvinder EVP & PRESIDENT, INTERNATIONAL Mar 10 '24 Option Exercise 0.00 1,179 0 1,179 Mar 12 05:10 PM DAVIS ROBERT T. JR. EVP & President, TT Mar 06 '24 Option Exercise 32.59 8,736 284,663 58,241 Mar 08 04:22 PM DAVIS ROBERT T. JR. EVP & President, TT Mar 06 '24 Sale 36.59 8,348 305,492 49,893 Mar 08 04:22 PM De Witte Jan President & CEO Jan 18 '24 Option Exercise 0.00 597 0 18,947 Jan 19 04:43 PM De Witte Jan President & CEO Nov 01 '23 Option Exercise 0.00 9,814 0 22,612 Nov 03 04:27 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
